Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.
2.

miR-381, a novel intrinsic WEE1 inhibitor, sensitizes renal cancer cells to 5-FU by up-regulation of Cdc2 activities in 786-O.

Chen B, Duan L, Yin G, Tan J, Jiang X.

J Chemother. 2013 Aug;25(4):229-38. doi: 10.1179/1973947813Y.0000000092. Epub 2013 May 7.

PMID:
23816136
3.

MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1.

Creevey L, Ryan J, Harvey H, Bray IM, Meehan M, Khan AR, Stallings RL.

Mol Cancer. 2013 Mar 26;12:23. doi: 10.1186/1476-4598-12-23.

4.

Regulation of cell cycle checkpoint kinase WEE1 by miR-195 in malignant melanoma.

Bhattacharya A, Schmitz U, Wolkenhauer O, Schönherr M, Raatz Y, Kunz M.

Oncogene. 2013 Jun 27;32(26):3175-83. doi: 10.1038/onc.2012.324. Epub 2012 Jul 30.

PMID:
22847610
6.
7.

Down-regulation of BTG1 by miR-454-3p enhances cellular radiosensitivity in renal carcinoma cells.

Wu X, Ding N, Hu W, He J, Xu S, Pei H, Hua J, Zhou G, Wang J.

Radiat Oncol. 2014 Aug 12;9:179. doi: 10.1186/1748-717X-9-179.

8.

Down-regulation of Wee1 kinase by a specific subset of microRNA in human sporadic pituitary adenomas.

Butz H, Likó I, Czirják S, Igaz P, Khan MM, Zivkovic V, Bálint K, Korbonits M, Rácz K, Patócs A.

J Clin Endocrinol Metab. 2010 Oct;95(10):E181-91. doi: 10.1210/jc.2010-0581. Epub 2010 Jul 28.

PMID:
20668041
9.
10.

MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma.

Ma X, Shen D, Li H, Zhang Y, Lv X, Huang Q, Gao Y, Li X, Gu L, Xiu S, Bao X, Duan J, Zhang X.

Urol Oncol. 2015 Apr;33(4):169.e1-11. doi: 10.1016/j.urolonc.2015.01.003. Epub 2015 Feb 17.

PMID:
25700976
11.

Discovery of gene expression-based pharmacodynamic biomarker for a p53 context-specific anti-tumor drug Wee1 inhibitor.

Mizuarai S, Yamanaka K, Itadani H, Arai T, Nishibata T, Hirai H, Kotani H.

Mol Cancer. 2009 Jun 8;8:34. doi: 10.1186/1476-4598-8-34.

12.

Tumour suppressive effects of WEE1 gene silencing in breast cancer cells.

Ghiasi N, Habibagahi M, Rosli R, Ghaderi A, Yusoff K, Hosseini A, Abdullah S, Jaberipour M.

Asian Pac J Cancer Prev. 2014 Jan;14(11):6605-11.

13.

Genistein induces G2/M arrest in gastric cancer cells by increasing the tumor suppressor PTEN expression.

Liu YL, Zhang GQ, Yang Y, Zhang CY, Fu RX, Yang YM.

Nutr Cancer. 2013;65(7):1034-41. doi: 10.1080/01635581.2013.810290. Epub 2013 Sep 20.

PMID:
24053672
14.

Arsenic trioxide induces G2/M arrest in hepatocellular carcinoma cells by increasing the tumor suppressor PTEN expression.

Zhang X, Jia S, Yang S, Yang Y, Yang T, Yang Y.

J Cell Biochem. 2012 Nov;113(11):3528-35. doi: 10.1002/jcb.24230.

PMID:
22730174
15.

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma.

Li X, Xin S, He Z, Che X, Wang J, Xiao X, Chen J, Song X.

Cell Physiol Biochem. 2014;33(6):1631-42. doi: 10.1159/000362946. Epub 2014 May 16.

16.

miRNA-34a suppresses cell proliferation and metastasis by targeting CD44 in human renal carcinoma cells.

Yu G, Li H, Wang J, Gumireddy K, Li A, Yao W, Tang K, Xiao W, Hu J, Xiao H, Lang B, Ye Z, Huang Q, Xu H.

J Urol. 2014 Oct;192(4):1229-37. doi: 10.1016/j.juro.2014.05.094. Epub 2014 May 24.

PMID:
24866595
17.

HCV core protein-induced down-regulation of microRNA-152 promoted aberrant proliferation by regulating Wnt1 in HepG2 cells.

Huang S, Xie Y, Yang P, Chen P, Zhang L.

PLoS One. 2014 Jan 9;9(1):e81730. doi: 10.1371/journal.pone.0081730. eCollection 2014.

18.

Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein (NOB1).

Li W, Liu M, Feng Y, Xu YF, Huang YF, Che JP, Wang GC, Yao XD, Zheng JH.

Br J Cancer. 2014 Sep 9;111(6):1188-200. doi: 10.1038/bjc.2014.382. Epub 2014 Jul 10.

19.

miRNA-221 promotes proliferation, migration and invasion by targeting TIMP2 in renal cell carcinoma.

Lu GJ, Dong YQ, Zhang QM, Di WY, Jiao LY, Gao QZ, Zhang CG.

Int J Clin Exp Pathol. 2015 May 1;8(5):5224-9. eCollection 2015.

Supplemental Content

Support Center